ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload (2010)
Sousa, L B; Okabe, C; Sena, C R; Ventura, B H; Fanelli, Camilla; Malheiros, D M A C; Zatz, Roberto; Fujihara, Clarice Kazue
Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: ÓXIDO NÍTRICO, SOLUÇÕES ELETROLÍTICAS, MODELOS ANIMAIS, RATOS, DOENÇA CRÔNICA (PREVENÇÃO E CONTROLE), ABLAÇÃO ANIMAL, NEFROPATIAS (PREVENÇÃO E CONTROLE), RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, L B et al. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2010
APA
Sousa, L. B., Okabe, C., Sena, C. R., Ventura, B. H., Fanelli, C., Malheiros, D. M. A. C., et al. (2010). Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Sousa LB, Okabe C, Sena CR, Ventura BH, Fanelli C, Malheiros DMAC, Zatz R, Fujihara CK. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. 2010 ; 65 S56.[citado 2024 nov. 17 ]
Vancouver
Sousa LB, Okabe C, Sena CR, Ventura BH, Fanelli C, Malheiros DMAC, Zatz R, Fujihara CK. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. 2010 ; 65 S56.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD) (2010)
Costa, S R; Valente, C P; Sena, C R; Fanelli, Camilla; Ventura, B H; Malheiros, D M A C; Zatz, Roberto; Fujihara, Clarice Kazue
Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: INSUFICIÊNCIA RENAL CRÔNICA (INDUZIDO QUIMICAMENTE), MODELOS ANIMAIS, RATOS, MEDICAMENTO (EFEITOS ADVERSOS), RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, S R et al. Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2010
APA
Costa, S. R., Valente, C. P., Sena, C. R., Fanelli, C., Ventura, B. H., Malheiros, D. M. A. C., et al. (2010). Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Costa SR, Valente CP, Sena CR, Fanelli C, Ventura BH, Malheiros DMAC, Zatz R, Fujihara CK. Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD). Clinics. 2010 ; 65 S38.[citado 2024 nov. 17 ]
Vancouver
Costa SR, Valente CP, Sena CR, Fanelli C, Ventura BH, Malheiros DMAC, Zatz R, Fujihara CK. Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD). Clinics. 2010 ; 65 S38.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure (2010)
Valente, C P; Costa, S R; Sena, C R; Fanelli, Camilla; Ventura, B H; David, D S R; Malheiros, D M A C; Zatz, Roberto; Fujihara, Clarice Kazue
Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: PRESSÃO SANGUÍNEA (CONTROLE), INSUFICIÊNCIA RENAL CRÔNICA, INSUFICIÊNCIA CARDÍACA, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALENTE, C P et al. Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2010
APA
Valente, C. P., Costa, S. R., Sena, C. R., Fanelli, C., Ventura, B. H., David, D. S. R., et al. (2010). Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Valente CP, Costa SR, Sena CR, Fanelli C, Ventura BH, David DSR, Malheiros DMAC, Zatz R, Fujihara CK. Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure. Clinics. 2010 ; 65 S58.[citado 2024 nov. 17 ]
Vancouver
Valente CP, Costa SR, Sena CR, Fanelli C, Ventura BH, David DSR, Malheiros DMAC, Zatz R, Fujihara CK. Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure. Clinics. 2010 ; 65 S58.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac) (2010)
Castro, M S de; Fanelli, Camilla; Poppi, E P B; Fernandes, Bianca Helena Ventura; Machado, F G; Malheiros, D M A C; Fujihara, Clarice Kazue; Zatz, Roberto
Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: INSUFICIÊNCIA RENAL CRÔNICA (INDUZIDO QUIMICAMENTE), NEFROPATIAS (INDUZIDO QUIMICAMENTE), MODELOS ANIMAIS, RATOS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, M S de et al. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2010
APA
Castro, M. S. de, Fanelli, C., Poppi, E. P. B., Fernandes, B. H. V., Machado, F. G., Malheiros, D. M. A. C., et al. (2010). High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Castro MS de, Fanelli C, Poppi EPB, Fernandes BHV, Machado FG, Malheiros DMAC, Fujihara CK, Zatz R. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. 2010 ; 65 S40.[citado 2024 nov. 17 ]
Vancouver
Castro MS de, Fanelli C, Poppi EPB, Fernandes BHV, Machado FG, Malheiros DMAC, Fujihara CK, Zatz R. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. 2010 ; 65 S40.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX) (2010)
Costa, S R; Souza, R A; Romagnoli, C; Fanelli, Camilla; Sena, C R; Ventura, B H; Malheiros, D M A C; Fujihara, Clarice Kazue; Zatz, Roberto
Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: NEFROPATIAS (INDUZIDO QUIMICAMENTE), MODELOS ANIMAIS, RATOS, ABLAÇÃO ANIMAL, TÚBULOS RENAIS (PATOLOGIA), RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, S R et al. Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2010
APA
Costa, S. R., Souza, R. A., Romagnoli, C., Fanelli, C., Sena, C. R., Ventura, B. H., et al. (2010). Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Costa SR, Souza RA, Romagnoli C, Fanelli C, Sena CR, Ventura BH, Malheiros DMAC, Fujihara CK, Zatz R. Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX). Clinics. 2010 ; 65 S38.[citado 2024 nov. 17 ]
Vancouver
Costa SR, Souza RA, Romagnoli C, Fanelli C, Sena CR, Ventura BH, Malheiros DMAC, Fujihara CK, Zatz R. Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX). Clinics. 2010 ; 65 S38.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Combined losartan and hydrochlorothiazide prevents progression of renal injury in chronic nephropathy resulting from losartan treatment (2007)
Fanelli, Camilla; Fernandes, Bianca Helena Ventura; Machado, F. G.; Poppi, E. P. B.; Malheiros, D. M. A. C.; Fujihara, Clarice Kazue; Zatz, Roberto
Source: Clinics. Conference titles: Simpósio avanços em pesquisas médicas. Unidade: FM
Subjects: NEFROPATIAS (INDUZIDO QUIMICAMENTE), MEDICAMENTO (EFEITOS ADVERSOS), RESUMOS (SIMPÓSIOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FANELLI, Camilla et al. Combined losartan and hydrochlorothiazide prevents progression of renal injury in chronic nephropathy resulting from losartan treatment. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2007
APA
Fanelli, C., Fernandes, B. H. V., Machado, F. G., Poppi, E. P. B., Malheiros, D. M. A. C., Fujihara, C. K., & Zatz, R. (2007). Combined losartan and hydrochlorothiazide prevents progression of renal injury in chronic nephropathy resulting from losartan treatment. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Fanelli C, Fernandes BHV, Machado FG, Poppi EPB, Malheiros DMAC, Fujihara CK, Zatz R. Combined losartan and hydrochlorothiazide prevents progression of renal injury in chronic nephropathy resulting from losartan treatment. Clinics. 2007 ; 62 S48.[citado 2024 nov. 17 ]
Vancouver
Fanelli C, Fernandes BHV, Machado FG, Poppi EPB, Malheiros DMAC, Fujihara CK, Zatz R. Combined losartan and hydrochlorothiazide prevents progression of renal injury in chronic nephropathy resulting from losartan treatment. Clinics. 2007 ; 62 S48.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Regression of diabetic nephropathy: no dose-response effect of an angiotensin II antagonist (2007)
Teles, Flavio; Fernandes, Bianca Helena Ventura; Sena, Claudia R.; Fanelli, Camilla; Poppi, Elizabete P. B.; Machado, Flavia G.; Malheiros, Denise M. A. C.; Fujihara, Clarice K.; Zatz, Roberto
Source: Clinics. Conference titles: Simpósio avanços em pesquisas médicas. Unidade: FM
Subjects: NEFROPATIAS, ANGIOTENSINA II (ANTAGONISTAS E INIBIDORES), RESUMOS (SIMPÓSIOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TELES, Flavio et al. Regression of diabetic nephropathy: no dose-response effect of an angiotensin II antagonist. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2007
APA
Teles, F., Fernandes, B. H. V., Sena, C. R., Fanelli, C., Poppi, E. P. B., Machado, F. G., et al. (2007). Regression of diabetic nephropathy: no dose-response effect of an angiotensin II antagonist. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Teles F, Fernandes BHV, Sena CR, Fanelli C, Poppi EPB, Machado FG, Malheiros DMAC, Fujihara CK, Zatz R. Regression of diabetic nephropathy: no dose-response effect of an angiotensin II antagonist. Clinics. 2007 ; 62 S44.[citado 2024 nov. 17 ]
Vancouver
Teles F, Fernandes BHV, Sena CR, Fanelli C, Poppi EPB, Machado FG, Malheiros DMAC, Fujihara CK, Zatz R. Regression of diabetic nephropathy: no dose-response effect of an angiotensin II antagonist. Clinics. 2007 ; 62 S44.[citado 2024 nov. 17 ]

USP Schools

ReP

Filtros

Authors

Subjects